Compounds > fluoxetine

fluoxetine and favipiravir

fluoxetine has been researched along with favipiravir in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Honkimaa, A; Hyöty, H; Sioofy-Khojine, AB1
Bamford, A; Booth, C; Breuer, J; Cheng, I; Chetty, K; Gonzalez-Granado, LI; Kaliakatsos, M; Klapsa, D; Martin, J1

Other Studies

2 other study(ies) available for fluoxetine and favipiravir

ArticleYear
A preclinical assessment to repurpose drugs to target type 1 diabetes-associated type B coxsackieviruses.
    Diabetic medicine : a journal of the British Diabetic Association, 2020, Volume: 37, Issue:11

    Topics: A549 Cells; Amides; Antiviral Agents; Azithromycin; Benzimidazoles; Coxsackievirus Infections; Diabetes Mellitus, Type 1; Drug Repositioning; Enterovirus B, Human; Fluoxetine; Guanidine; Humans; Immunoglobulin G; Lovastatin; Oxadiazoles; Oxazoles; Oximes; Pyrazines; Ribavirin; Sulfonamides

2020
Case report: Novel treatment regimen for
    Frontiers in immunology, 2022, Volume: 13

    Topics: Amides; Antiviral Agents; Encephalitis, Viral; Enterovirus; Enterovirus Infections; Fluoxetine; Humans; Immunoglobulins, Intravenous; Infant; Male; Pyrazines

2022